OphthaFund
Overview
OphthaFund is an early-stage venture capital firm specializing in ophthalmology and life sciences investments. The firm focuses on connecting investors with innovative ideas in the ophthalmic sector, aiming to advance emerging ophthalmic technologies. OphthaFund's directors provide extensive research into intellectual property, company guidance, and proposed markets for start-ups and emerging technologies. They work collaboratively with investors to select top companies in the industry, supporting and guiding strategic investments. With a diversified investment portfolio, OphthaFund has led numerous successful investments through funding rounds for innovators within the ophthalmology industry. The firm's mission is to eradicate major eye diseases worldwide by partnering with the right strategic partners and implementing effective industry solutions. OphthaFund maintains a meticulous and rigorous approach to due diligence, ensuring thorough evaluation of investment opportunities. Their aim is to identify ventures with compelling value propositions, strong market potential, and clear pathways to commercialization. The firm's founders have a deep track record in ophthalmology and biotechnology, offering drug development expertise and connections to a network of investors, partners, and subject matter experts. This experience enhances OphthaFund's credibility and effectiveness in supporting innovative solutions in the ophthalmology and biotechnology sectors.
Investment Focus
- Strong market potential
- Clear pathway to commercialization
- Innovative solutions in ophthalmology and life sciences
Portfolio Companies
Reach OphthaFund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about OphthaFund
What sectors does OphthaFund invest in?
OphthaFund invests in HealthTech, Life Sciences, Healthcare Services, Pharmaceuticals, Medical Devices and Medtech, and is based in Charleston, United States. OphthaFund is listed as a venture capital in the ConnectSafely investor database.
What stage does OphthaFund invest at?
OphthaFund backs companies at Seed, Series A and Series B, writing cheques of 1M - 5M.
Which regions does OphthaFund invest in?
OphthaFund invests across United States.
Who are the partners at OphthaFund?
Team members listed for OphthaFund include Andrea Marshall (Co-Founder and Managing Principal).
What companies has OphthaFund invested in?
OphthaFund's portfolio includes ONL Therapeutics, MCAL Therapeutics, Encore Pharmaceuticals, ForwardVue Pharma, Premark Pharma and Allysta Pharmaceuticals.
How do I contact OphthaFund?
OphthaFund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
